PRODUCTS & INNOVATION
New collaboration will integrate Abbott’s FreeStyle Libre system’s glucose data with Sanofi’s insulin dosing.
Sep 16 2019
You’re judged by the company you keep.
That’s why we started collaborating with Bigfoot and Novo Nordisk to connect our world-leading FreeStyle Libre flash glucose monitoring system with their world-class insulin delivery systems, including Bigfoot’s user-friendly systems intended to optimize insulin delivery as well as Novo Nordisk’s connected insulin pens.
And it’s why we’re now joining forces with Sanofi to integrate FreeStyle Libre technology with Sanofi’s insulin dosing information for future smart pens, insulin titration apps and cloud software.
It’s a good group, this network of diabetes care experts. And we all have one big goal in common: The commitment to employing life-changing technology to make diabetes management as simple, easy and effective as it can be.
“Diabetes can be overwhelming. It’s an information-rich condition with various streams of data from multiple devices,” said Jared Watkin, senior vice president, Diabetes Care, Abbott. “Building a digital ecosystem around FreeStyle Libre simplifies the user experience by consolidating how people get their data — both through offering Abbott’s digital health tools and by working with other diabetes and technology leaders.”
Those tools include connected apps, FreeStyle LibreLink (which helps you monitor your glucose via a smartphone) as well as Libre LinkUp (which allows your loved ones to view your results after you scan).
With Sanofi on board, it’s a bigger digital healthcare ecosystem where information and data will be designed to share between FreeStyle Libre and our partner’s digital health tools, offering users personalized care.
As the world leader in sensor-based glucose monitoring, the FreeStyle Libre system is improving the lives of more than 1.5 million peoplei. With these partnerships, we’ll be able to improve the lives of millions more as they manage their condition.
These are connected device experiences that are connecting people with better care.
It’s what friends are for.
i Data on file, Abbott Diabetes Care. Data based on the number of users worldwide for the FreeStyle Libre system compared to the number of users for other leading personal use, sensor-based glucose monitoring systems.
BinaxNOW + NAVICA App Among Chicago's Best Innovations
Honoring Achievements from Women in STEM
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.